Evodia Fruit is not a commodity that should be purchased by color, bitterness, or price alone. This procurement guide explains how professional buyers should verify Wu Zhu Yu identity, potency, processing, contamination risks, and supplier control before approving a bulk lot.
Cheap lots lie.
A shipment of Evodia Fruit can look dark, smell forceful, taste aggressively bitter, and still fail the commercial questions that matter: Is it the approved botanical source, was it harvested at the right stage, does the lot meet its marker specification, and can the supplier prove where it came from?
So why do buyers still approve it by photograph?
Evodia Fruit, also traded as Wu Zhu Yu or Euodiae Fructus, is not a simple dried fruit. It is a chemically active herbal material with several accepted historical source names, marked variation between harvest periods, a strong sensory profile, and documented toxicity concerns that make casual procurement especially reckless.
I take a hard position here: a bitter sample is not a potency certificate, and a polished COA is not proof of supplier control.
Professional procurement begins with identity. It continues with an agreed specification. It ends only when the commercial shipment matches the approved sample and the evidence survives review.
The first purchasing risk appears before a laboratory ever touches the sample.
“Evodia Fruit” is a commercial name. “Wu Zhu Yu” is the Chinese materia medica name. “Euodiae Fructus” is the pharmacopoeial drug name. Meanwhile, Evodia rutaecarpa, Euodia ruticarpa, and Tetradium ruticarpum may appear across specifications, research papers, customs documents, catalogs, and certificates.
These names are not interchangeable without explanation.
The Royal Botanic Gardens, Kew, treats Tetradium ruticarpum (A.Juss.) T.G.Hartley as the accepted botanical name and lists Euodia ruticarpa as a synonym in its Plants of the World Online taxonomic record. Pharmacopoeial and commercial documents, however, often retain older Evodia or Euodia terminology.
That creates a paperwork trap.
A buyer may receive:
All five may refer to the intended material, but only if the supplier has formally reconciled the names.
My rule is simple: the specification should state the accepted botanical name, recognized pharmacopoeial synonyms, plant family, plant part, drug name, processing form, and country or region of origin. “Latin name: Euodiae Fructus” is incomplete because Euodiae Fructus is a drug name, not a full binomial botanical identity.
Buyers reviewing the available bulk Evodia Fruit product specification should therefore use the product page as the start of an inquiry, not the end of botanical verification.
A serious identity file should contain:
The Hong Kong Department of Health’s Fructus Evodiae identification guide documents practical microscopic features including oil-secretory cavities, exocarp cells, mesocarp cells, calcium oxalate crystals, and stone cells. Its separate Fructus Evodiae comparison guide highlights macroscopic features such as the five-pointed fissure at the apex and dotted protuberances or oil spots on the surface.
This matters because identity is not established by a supplier writing the correct name in Excel.
Identity must be demonstrated.
Buyers frequently ask for “high evodiamine content” as though potency were a setting that the laboratory turns up after production.
It is not.
Potency begins in the field, where species, genetics, location, climate, fruit maturity, harvest date, drying conditions, storage duration, and processing method influence the chemical profile before the supplier creates a certificate.
A 2025 study on growth and harvest timing found that the optimal collection point for immature E. officinalis fruit was approximately two weeks after flowering, when the fruit combined higher weight and active-ingredient content without having dehisced. The study measured seasonal changes in evodiamine and rutaecarpine rather than assuming every harvest was chemically equivalent. Buyers can review the full harvest-timing study in the National Library of Medicine archive.
That finding should not be blindly converted into a universal two-week purchasing rule for every source species. It does prove something more useful: harvest timing can materially alter commercial quality.
Yet many COAs state only:
No harvest date. No maturity stage. No chromatogram. No explanation of the test method.
That is documentation theater.
According to reviews summarizing the 2020 Chinese Pharmacopoeia requirements, Euodiae Fructus should contain:
The HPLC method described in the literature uses detection at 225 nm. The broader chemistry, processing, safety, and quality-control discussion is available in the 2025 Frontiers in Pharmacology review of Euodiae Fructus.
These values provide a defensible reference point. They are not permission to copy two numbers into every global specification.
The applicable pharmacopoeia, product classification, processing form, destination country, dosage form, customer agreement, and regulatory route still control the final acceptance limits. A food ingredient, dietary supplement component, traditional medicine ingredient, extract feedstock, and pharmaceutical raw material may require different documentation and release logic.
For evodiamine content and related marker testing, I would ask for:
A one-line “evodiamine: pass” result is not quantitative evidence.
And “tested by HPLC” is not a method.
Evodia Fruit should not taste mild and anonymous. Its traditional sensory description is pungent, bitter, aromatic, and warming, and a weak or stale sensory profile can signal ageing, poor storage, over-processing, dilution, or a mismatched material.
But bitterness creates false confidence.
Very bitter material is not automatically more potent. A buyer cannot taste a sample and calculate combined evodiamine and rutaecarpine content. Nor can a purchasing manager detect pesticide residues, lead, arsenic, aflatoxins, pathogenic microorganisms, or sulfur-treatment problems by chewing one fruit.
Still, sensory review has value when it is controlled.
Instead of writing “strong bitterness” in an email, define a comparative procedure:
The point is not to turn purchasing staff into human chromatographs.
The point is to detect change.
A new lot that is dramatically weaker, sharper, smokier, mustier, or chemically different from the approved reference deserves investigation even when its basic COA values pass.
Processing can change sensory character and chemical composition.
Euodiae Fructus may be supplied raw or processed, including traditional processing associated with licorice preparations. Research reviews note that processing can reduce toxicity, while also changing constituent profiles. That makes “processed Wu Zhu Yu” a material definition, not a marketing adjective.
Your specification should answer:
Do not approve a raw sample and receive processed commercial stock. Do not approve processed material without knowing how the processing was controlled.
The following table is a commercial starting point, not a replacement for destination-market regulatory review.
| Control Item | What the Buyer Should Define | Evidence to Request | Typical Rejection Trigger |
|---|---|---|---|
| Product identity | Euodiae Fructus/Wu Zhu Yu with accepted species and synonyms | Macroscopy, microscopy, TLC/HPTLC or validated identity method | Species, plant part, or synonym chain cannot be reconciled |
| Plant part | Dried, nearly ripe fruit | Raw-material record and visual inspection | Excess stems, leaves, open debris, or unrelated fruit |
| Origin | Country, province, growing area, supplier or farm source | Traceability record and purchase record | Mixed or undisclosed origin |
| Harvest | Harvest year, period, and maturity stage | Harvest or procurement record | Old crop sold as current crop or no harvest information |
| Processing | Raw or named processed form | Batch process record | Processing method differs from approved sample |
| Evodiamine and rutaecarpine | Agreed individual and combined HPLC limits | Lot-specific assay and chromatogram | Result below specification or unexplained method change |
| Limonin | Agreed quantitative limit | HPLC result | Below specification |
| Sensory character | Defined pungency, aroma, bitterness, and absence of off-notes | Approved reference and inspection record | Musty, smoky, rancid, unusually weak, or foreign odor |
| Moisture | Buyer-defined maximum based on form and storage plan | Validated moisture result | Above limit or uneven moisture across bags |
| Foreign matter | Quantified maximum | Sorting and inspection record | Excess dust, stems, stones, insects, or unrelated botanical matter |
| Heavy metals | Destination-specific lead, arsenic, cadmium, and mercury limits | ICP-MS or equivalent report | Any result above the agreed legal or buyer limit |
| Pesticides | Market-specific multi-residue panel | GC-MS/MS and LC-MS/MS report | Prohibited compound or residue above limit |
| Microbiology | Total counts plus specified pathogens where applicable | Lot-specific microbial report | Salmonella, unacceptable pathogens, or counts above limit |
| Mycotoxins | Risk-based aflatoxin or broader panel | Accredited laboratory report | Above destination limit |
| Sulfur dioxide | Declared treatment status and agreed residual limit | Quantitative test | Undeclared treatment or excessive residue |
| Packaging | Food- or pharmaceutical-contact suitable inner packaging, lot coding, net weight | Packaging specification and photographs | Unsealed, wet, damaged, or incorrectly coded bags |
| Retained sample | Sealed reference from the shipped lot | Supplier retention record | No retention policy or sample does not match shipment |
| Change control | Notification before source, process, lab, method, or packaging changes | Signed quality agreement | Unapproved change discovered after shipment |
The hardest part is not writing this table.
The hardest part is enforcing it when a supplier says, “The result is almost the same.”
Almost is expensive.
A bulk Evodia fruit supplier should be evaluated as a system, not as a salesperson with access to laboratory templates.
I would separate the review into five layers.
The supplier should know who grew or collected the fruit, where it was produced, how the source was approved, and how incoming lots are separated.
For buyers comparing multiple fruit and seed materials, the site’s wholesale fruit and seed Chinese medicines catalog provides the relevant product family. But a category page proves range, not traceability. Traceability requires farm, collector, warehouse, intake, and batch records.
Ask whether lots from different regions or harvest years are blended.
Then ask why.
Blending is not automatically wrong. Undisclosed blending is.
Each incoming lot should be quarantined until identity and condition are reviewed. The receiving record should capture supplier, origin, lot code, quantity, packaging condition, harvest information, inspection result, sampling details, and disposition.
Never assume that the beautiful pre-shipment sample came from the same lot loaded into your order.
Use sealed counter-samples. Match lot codes. Sample multiple bags.
The laboratory should use methods suitable for the material and intended decision. Identity, potency, contamination, and processing checks are different questions and may require different methods.
A generic COA copied across harvests is worse than useless because it creates false assurance.
The FDA’s August 2025 dietary supplement compliance program lists failures such as missing ingredient specifications, inadequate identity testing, unsuitable test methods, missing quality-control procedures, and failure to confirm that finished batches meet release criteria. The enforcement framework can be reviewed in the FDA’s Dietary Supplements Compliance Program 7321.008.
For companies placing botanical products into the US dietary supplement channel, FDA’s CGMP compliance guide explains that 21 CFR Part 111 requires written quality systems, specifications, quality-control operations, traceable lot identifiers, and appropriate handling of rejected materials.
A foreign supplier’s certificate does not transfer the importer’s responsibility.
Evodia Fruit contains aromatic and chemically active constituents. Heat, moisture, oxygen, storage time, pests, and poor warehouse discipline can change the material before shipment.
The supplier should control:
GuoCao states that it operates GMP-certified processing lines, ISO 22000 controls, seven planting bases, controlled storage, third-party testing, and annual capacity of approximately 2,500 tons on its Chinese herbal manufacturer profile. Those are commercially relevant claims, but buyers should still request current certificates, scope pages, batch records, test reports, and evidence tied to the Evodia lot under review.
A certificate logo is not an audit.
This is where weak suppliers become visible.
Ask what happens when:
The supplier should have a written investigation process, root-cause analysis, corrective and preventive action, retained-sample review, replacement procedure, and responsibility for costs.
“Next order discount” is not corrective action.
Buyers needing custom grinding, slicing, blending, packaging, or documentation should define these controls through the site’s herbal blending, milling, and custom processing service, rather than adding processing requirements after the raw material has already been purchased.
The 2025 Japanese harvest study measured evodiamine and rutaecarpine across collection periods and identified an optimal stage for immature E. officinalis fruit at about two weeks after flowering.
The procurement lesson is blunt: “same herb” does not mean “same chemistry.”
A supplier that cannot state harvest period or maturity stage cannot adequately explain potency variation.
In a September 2024 warning letter, the FDA told Far East Summit LLC that botanical dietary ingredients are frequently at risk of heavy-metal, microbial, and pesticide contamination because of growing, harvesting, and processing conditions. The agency specifically criticized the absence of adequate component contaminant specifications.
The full FDA warning letter to Far East Summit LLC should be required reading for anyone who believes a botanical supplier’s “natural” claim reduces testing obligations.
Natural is not clean.
Kew recognizes Tetradium ruticarpum as the accepted name, while pharmacopoeial and commercial records continue to use Evodia and Euodia terminology.
This is not academic wordplay. Conflicting botanical names can trigger customer questions, laboratory mismatches, customs delays, label inconsistency, and rejected technical files.
A good specification resolves the naming chain before shipment.
Before approving a bulk order, I would require affirmative answers to these questions:
One “no” may be explainable.
Five vague answers usually tell the whole story.
Evodia Fruit is the dried, nearly ripe fruit used in Chinese materia medica as Euodiae Fructus or Wu Zhu Yu, generally sourced from Tetradium ruticarpum and its pharmacopoeial legacy synonyms, and evaluated through botanical identity, sensory traits, chemical markers, contaminant testing, processing status, and lot-level traceability.
It is commonly traded under the older name Evodia rutaecarpa, although modern botanical databases may use Tetradium ruticarpum. Buyers should include both accepted and recognized legacy names in specifications to prevent document mismatches.
Evodia Fruit potency is the measurable chemical and material consistency of a commercial lot, usually assessed through confirmed species identity, HPLC marker assays such as combined evodiamine and rutaecarpine plus limonin, controlled moisture and foreign matter, appropriate processing, and comparison against an agreed pharmacopoeial or buyer specification.
The 2020 Chinese Pharmacopoeia thresholds summarized in published reviews are at least 0.15% combined evodiamine and rutaecarpine and at least 0.20% limonin. Buyers must still confirm which standard legally and commercially applies to their destination and product category.
Evodia Fruit bitterness is a sensory quality attribute associated with the herb’s expected pungent-bitter character, but it is not a numerical potency test and cannot replace HPLC assay data, botanical identification, chromatographic fingerprinting, or contaminant results when a buyer releases a commercial batch for manufacturing or distribution.
Strong bitterness may support a sensory comparison with an approved reference. It cannot show the exact evodiamine content or confirm that the material is free from pesticides, heavy metals, microorganisms, mycotoxins, or undeclared processing residues.
A reliable bulk Evodia fruit supplier is a manufacturer or qualified processor that can connect every shipment to an approved botanical source, harvest and processing records, representative sampling, lot-specific testing, traceable packaging, controlled storage, deviation handling, and written responsibility for investigation, replacement, or corrective action when a batch fails.
The supplier should also provide current certification scopes, lot-specific COAs, method details, chromatograms when requested, retained samples, change-control notices, and evidence that the commercial shipment matches the approved reference.
To source Evodia Fruit safely, define the accepted species and synonyms, plant part, raw or processed form, sensory profile, marker limits, contaminant panel, packaging, destination-market documents, sampling method, and rejection rules before requesting quotations, then verify the supplier with retained samples, independent testing, and repeat-lot performance.
Do not select a supplier solely by kilogram price. Compare total procurement risk, including testing gaps, customs documentation, batch inconsistency, rejected production, rework, replacement freight, regulatory exposure, and the supplier’s response when evidence contradicts its COA.
Do not ask only for “your best Evodia price.”
Send a purchasing specification that includes your destination country, application, required botanical identity, raw or processed form, annual volume, trial quantity, target evodiamine and rutaecarpine level, limonin requirement, contaminant limits, packaging format, laboratory documentation, and expected delivery schedule.
Then request:
Use the GuoCao wholesale and OEM inquiry page to submit your Evodia Fruit specification and request a traceable sample, technical documents, testing options, packaging details, and a commercial quotation.
Buy the evidence.
Not the bitterness.
